Navigation Links
GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operational Update
Date:8/7/2009

evelop and manufacture these vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective or easier to use than GeoVax's products, and other factors over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. Certain matters discussed in this news release are forward-looking statements involving certain risks and uncertainties including, without limitation, risks detailed in the Company's Securities and Exchange Commission filings and reports.


                                  GEOVAX LABS, INC.
             Condensed Consolidated Statements of Operations Information
                  (amounts in thousands, except per share data)


                                           Three Months        Six Months
                                              Ended              Ended
                                             June 30,           June 30,
                                             --------           --------
                                          2009      2008      2009      2008
                                          ----      ----      ----      ----
      Revenues
        Grant Revenue                     $753      $376    $1,463      $976

      Operating expenses:
        Research and development         1,203       759     2,060     1,363
        General and administrative         906       918     1,630     1,623
                                           ---       ---     -----     -----
                                         2,109     1,677     3,690     2,986
                                       
'/>"/>
SOURCE GeoVax Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. GeoVax Co-Founder Dr. Harriet Robinson Named 2007 AAAS Fellow
2. Nortech Labs, Inc. and MEDNET(TM) Make for a Notable, Natural Partnership
3. Scarguard Labs, LLC Appoints Richard E. Pino as CFO
4. Scarguard Labs, LLC Expands Distribution Reach Through Agreements With McKesson Drugs and Publix Supermarkets
5. Innovatech Labs, Assisting Companies in Adhering to Halogen-Free Manufacturing Standards Aimed at Protecting the Environment
6. ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding
7. NATB Announces Partnership With Ronald McDonald House Charities(R)
8. LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense
9. ThermoGenesis Announces Launch of Res-Q System; New Device Expands Companys Presence in Bone Marrow Sector
10. Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
11. AMN Healthcare Announces Second Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... People who struggle to distinguish between a business ... and get the answer by reading Per Wickstrom’s latest ... that a business plan and a business strategy are both ... Wickstrom. “The way I view it is that a business ... is part two.” , According to the blog post, ...
(Date:9/17/2014)... IL (PRWEB) September 17, 2014 The ... Pseudomonas aeruginosa infections allegedly caused by Non-Sterile Other-Sonic ... learn more about their options for legal recourse. Other-Sonic ... Drug Administration (FDA) in March 2012, after the product ... aeruginosa at William Beaumont Hospital in Royal Oak, Michigan ...
(Date:9/17/2014)... Dennis Thompson HealthDay ... -- Exposure in the womb to household chemicals known ... developing asthma, Columbia University researchers reported in a new ... risk of developing asthma between age 5 and 11 ... levels of two phthalates (pronounced thal-ates), the researchers found. ...
(Date:9/17/2014)... Texas (PRWEB) September 17, 2014 Prevention ... outbreak that is hospitalizing scores of infants, children and ... says Dr. Kirk Mahon, medical director of Legacy ER ... “There have been no reported cases of EV-D68 so ... and Louisiana, that could change,” he said. “Implementing prevention ...
(Date:9/17/2014)... 2014 Smart Flour Foods™ has been ... Grocer, a leading trade magazine targeted toward food retailers. ... and flavor, among other attributes. Smart Flour Foods’ Uncured ... in the September print issue of Progressive Grocer as ... pizza won based on its superior performance in the ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom’s Latest Blog Explores the Difference Between a Business Plan and a Business Strategy 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 3Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 4Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 2Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 3Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 4Health News:Legacy ER & Urgent Care Warns North Texans about Dangers of Enterovirus D68 2Health News:Smart Flour Foods Wins 2014 Progressive Grocer Editor’s Pick Award 2
... for the purpose of drug testing which is currently ... at the University of Manchester, well supported with a ... carcinogenic effects of new drugs are often fruitless using ... animals to establish their safety. ,Gentronix , a ...
... are the latest to join the fight against HIV with ... clients.// They have been recruited as part of an innovative ... the British government. This donation is expected to aid in ... by increasing testing and encouraging safer sex. ...
... gain at bay, says a Rhode Island researcher. Much like ... dismissed// as the fertile imagination of a maverick researcher, which ... control programmes. And while you weigh the pros and cons ... story of why the most famous ‘don’t’ of almost all ...
... Fresh statistics show a phenomenal rise in sexually transmitted ... of the most common treatable sexually transmitted diseases affecting ... in its incidence rates across the Australian subcontinent. with ... younger age groups with no gender distinction among the ...
... Haryana: This one's a very different kind of war for ... some. You bomb bacteria, not civilian populations//. And the retired ... the past 13 years. ,What began in 1993 ... and Leprosy Eradication (ABLE). Made possible through generous NRI funding ...
... Diligent study has helped telemedicine researchers at University of Queensland ... virtually shrinking ominous distances between cities and remote settlements in ... Eliza was created by the Centre for Online Health one ... Which is affiliated to the University of Queensland, Eliza ...
Cached Medicine News:Health News:Grant Encourages Drug Testing Sans Animals 2Health News:Tilt the Scales in Your Favor by Simply Weighing Yourself Everyday! 2Health News:Sexually Transmitted Diseases Soaring Due To Unsafe Sex 2Health News:Robots Help Bring Specialist Doctors To You In A Trice 2
(Date:9/17/2014)... EMERYVILLE, Calif. , Sept. 17, 2014 /PRNewswire/ ... newest data analytics solution that brings complete visibility ... minimize risks in an ever-evolving reimbursement landscape. Powered ... Integrity brings transparency to the critical point between ... operations impact revenue. The solution will improve revenue ...
(Date:9/17/2014)... -- Women everywhere know how frustrating a vaginal infection ... often also embarrassing and have a way of derailing ... http://ph-defense.com ) is a new, over-the-counter product designed to ... Odor, discharge, and discomfort or itch ... many cases, the cause of such problems can be ...
(Date:9/17/2014)... , Sept. 17, 2014  Aratana Therapeutics, Inc. (NASDAQ: ... focused on licensing, developing and commercializing innovative biopharmaceutical ... of its public offering of 4,500,000 shares of its common ... $9.25 per share. Aratana has granted the underwriters ... additional 675,000 shares of its common stock. ...
Breaking Medicine Technology:MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 2MedeAnalytics Unveils New Revenue Integrity Solution to Support the Transition to Value-Based Healthcare 3New Product from Vireo Systems: pH-D Feminine Health Support 2Aratana Therapeutics, Inc. Announces Pricing of Public Offering 2
... Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today ... midazolam injection, USP, a general anesthetic.  Sagent expects ... latex-free vials, in 2011.  According to 2010 IMS ... approximated $52 million.   "Approval of ...
... Genous Stent shows favorable outcomes compared to bare metal stents ... to data published online in the journal Atherosclerosis ... primary endpoint, the composite of cardiac death, myocardial infarction (MI) ... 12.4% in patients treated with a Genous Stent, a 30% ...
Cached Medicine Technology:Sagent Pharmaceuticals Announces FDA Approval of Midazolam Injection, USP 2OrbusNeich's Genous™ Stent Shows Favorable Outcomes for Treatment of Coronary Artery Bifurcation Lesions Compared to Bare Metal Stents 2
... The Vitros ECi brings true ... to immunodiagnostic testing. Highly sensitive assays ... oncology and bone metabolism testing are ... under development. The Vitros ECi can ...
... is a flexible system that ... environments small hospitals, backup ... satellite locations. The Vitros 250 ... can be automated or placed ...
... an effort to improve on the ... toxicology, abused drugs, and immunosuppressants tests, ... which incorporates random access capabilities. Although ... undergone several important changes in the ...
The IMx system is an automated analyzer designed to perform microparticle enzyme immunoassay (MEIA), fluorescence polarization immunoassay (FPIA) and ion capture technologies....
Medicine Products: